Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Nakagawa, H. Murase, K. Furuta, K. Morita, K. Maniwa, T. Ikeue, T. Sugita, S. Horikawa, H. Nishiyama (Japan). Treatment and prognosis of lung cancer associated with interstitial pneumonia. Eur Respir J 2010; 36: Suppl. 54, 3278

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer is frequently developed in patients with idiopathic interstitial pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 579s Year: 2007 The burden of emphysema on lung cancer prognosis Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Chronic eosinophilic pneumonia after radiation therapy for breast cancer Source: Eur Respir J 2004; 23: 9-13 Year: 2004 Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients Source: Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017 Year: 2017 Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Chronic eosinophilic pneumonia after radiation therapy for breast cancer Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Clinical course of pneumonia in lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2014; 43: 1529-1530 Year: 2014 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2013; 42: 750-757 Year: 2013 Surgical morbidity and mortality in lung cancer patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006 Management of concomitant COPD in patients with lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Lung cancer and interstitial lung disease Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 The Asian experience in co-existing lung cancer and interstitial lung disease Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018